Natco Pharma Ltd.
BSE: 524816 | NSE: NATCOPHARM
Small Cap | Pharmaceuticals & Drugs
897.05
1.15
(0.13%)
< Home
< Back
Natco Pharma Ltd. News
>>
Natco Pharma jumps on getting emergency use approval for Baricitinib tablets for Covid-19 treatment
>>
Natco Pharma gets emergency use approval from CDSCO for Baricitinib tablets for Covid-19 treatment
>>
Natco Pharma informs about press release
>>
Natco Pharma applies to CDSCO for Phase-III clinical trial of Molnupiravir Capsules for Covid-19 treatment
>>
Natco Pharma surges as its distribution partner gets tentative approval for Ibrutinib tablets
>>
Natco Pharma's distribution partner gets tentative approval for Ibrutinib tablets
>>
Natco Pharma gets nod to acquire 0.96% stake in NATCO Pharma Canada Inc.
>>
Natco Pharma rises on foraying into Pheromone based technology for IPM
>>
Natco Pharma forays into Pheromone based technology for IPM
>>
Natco Pharma informs about press release
<<
<
20
21
22
...52
>
>>